1.7600
21-February-25 15:45:00
15 minutes delayed
Stocks
-0.0500
-2.76%
Today's range
1.7600 - 1.9000
ISIN
N/A
Source
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 Oct 2022 08:00:00 By Nasdaq GlobeNewswire